Funding for this research was provided by:
Rogel Cancer Center, University of Michigan (P30-CA046592)
Division of Cancer Epidemiology and Genetics, National Cancer Institute (R21-CA187537)
Foundation for the National Institutes of Health (R01-CA158286)
University of Michigan Specialized Programs of Research Excellence (P50-CA097248)
Received: 10 June 2020
Accepted: 3 November 2020
First Online: 17 November 2020
Ethics approval and consent to participate
: The study was approved by the University of Michigan Institutional Review Board. All patients have given written consent for the study. The experimental methods comply with the Helsinki Declaration.
: Not applicable.
: The authors declare that they have no competing interests.